ANL 29.80 Decreased By ▼ -1.55 (-4.94%)
ASC 20.40 Decreased By ▼ -0.50 (-2.39%)
ASL 23.60 Decreased By ▼ -0.30 (-1.26%)
BOP 8.26 Decreased By ▼ -0.15 (-1.78%)
BYCO 9.88 Decreased By ▼ -0.16 (-1.59%)
FCCL 21.85 Decreased By ▼ -0.35 (-1.58%)
FFBL 26.91 Decreased By ▼ -0.53 (-1.93%)
FFL 20.00 Decreased By ▼ -0.79 (-3.8%)
FNEL 8.74 Decreased By ▼ -0.11 (-1.24%)
GGGL 26.40 Decreased By ▼ -1.05 (-3.83%)
GGL 46.04 Decreased By ▼ -1.06 (-2.25%)
HUMNL 7.05 Decreased By ▼ -0.35 (-4.73%)
JSCL 21.62 Decreased By ▼ -0.88 (-3.91%)
KAPCO 38.70 Decreased By ▼ -1.10 (-2.76%)
KEL 3.90 Decreased By ▼ -0.02 (-0.51%)
MDTL 3.56 Decreased By ▼ -0.17 (-4.56%)
MLCF 43.50 Decreased By ▼ -0.77 (-1.74%)
NETSOL 158.50 Decreased By ▼ -7.45 (-4.49%)
PACE 7.45 Decreased By ▼ -0.22 (-2.87%)
PAEL 33.65 Decreased By ▼ -0.36 (-1.06%)
PIBTL 11.00 Decreased By ▼ -0.25 (-2.22%)
POWER 9.20 No Change ▼ 0.00 (0%)
PRL 23.00 Decreased By ▼ -0.80 (-3.36%)
PTC 11.60 Decreased By ▼ -0.13 (-1.11%)
SILK 1.83 Increased By ▲ 0.01 (0.55%)
SNGP 49.80 Increased By ▲ 0.20 (0.4%)
TELE 14.80 Decreased By ▼ -0.26 (-1.73%)
TRG 159.45 Decreased By ▼ -6.75 (-4.06%)
UNITY 40.45 Decreased By ▼ -2.52 (-5.86%)
WTL 3.59 Decreased By ▼ -0.15 (-4.01%)
BR100 5,096 Decreased By ▼ -70.59 (-1.37%)
BR30 25,755 Decreased By ▼ -734.03 (-2.77%)
KSE100 47,318 Decreased By ▼ -368.96 (-0.77%)
KSE30 18,974 Decreased By ▼ -155.31 (-0.81%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,133
4424hr
Pakistan Cases
1,015,827
4,11924hr
7.88% positivity
Sindh
371,762
Punjab
354,312
Balochistan
29,861
Islamabad
86,226
KPK
142,400
World

Norway keeps AstraZeneca vaccine on hold for another 3 weeks

  • "We have decided to continue the pause and make a new decision by April 15," FHI chief Camilla Stoltenberg told broadcaster NRK.
  • "We have started several processes to map out whether there is a causality and to have a better basis to establish the real risk and a cost-benefit analysis for different age groups. To get more knowledge, it is necessary to have more time."
26 Mar 2021

OSLO: Norway will delay its decision on whether to resume the use of AstraZeneca's COVID-19 vaccine by up to three weeks, the Norwegian Institute of Public Health (FHI) said on Friday.

Authorities on March 11 suspended the rollout of the vaccine after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.

"We have decided to continue the pause and make a new decision by April 15," FHI chief Camilla Stoltenberg told broadcaster NRK.

"We have started several processes to map out whether there is a causality and to have a better basis to establish the real risk and a cost-benefit analysis for different age groups. To get more knowledge, it is necessary to have more time."

Norway is one of over a dozen European countries to have suspended the rollout of the vaccine over safety concerns, although most nations have since resumed its use on the advice of the European Medicines Agency (EMA).

The shot remain on hold in neighbouring Denmark however, while other Nordic countries have decided to use it for older age groups.

The EMA has said the shot's benefits in protecting people from coronavirus-related death or hospitalisation outweighed the possible risks. The World Health Organization has also backed the vaccine.

AstraZeneca has said a review of safety data of more than 17 million people inoculated in the United Kingdom and European Union with its vaccine had shown no evidence of an increased risk of blood clots.

Norway has reported five cases in which recipients of the AstraZeneca vaccine were later admitted to hospital with the combination of blood clots, bleedings and low platelets, three of whom have died.

A sixth person, who also got the vaccine, died from brain a haemorrhage in combination with a low count of platelets, health authorities have said.

Norway has been using vaccines developed by Pfizer/BioNTech and Moderna and hopes to use Johnson & Johnson's once supplies become available in Europe.

The non-EU country is getting its vaccines via the European procurement programme, thanks to Sweden buying more shots than it needs and then passing them on to its neighbour.

Norway has had some of Europe's lowest rates of infections and deaths since the start of the pandemic early last year, but is now seeing a rapid increase in hospitalisations led by more contagious variants of the virus.